Related Experiment Videos
Use of co-trimoxazole in chronic renal failure
Abstract:
Twenty patients with chronic renal failure and either urinary or respiratory tract infection were treated with co-trimoxazole. Seventeen patients showed no deterioration in renal function while receiving co-trimoxazole. Deterioration in renal function during treatment in the other three patients was due to factors other than administration of the drug. It is concluded that co-trimoxazole can be used in patients with chronic renal failure provided the dose is adjusted according to the degree of renal failure.
Insights
Co-trimoxazole is safe for patients with chronic renal failure when the dosage is adjusted. Most patients experienced no decline in kidney function during treatment, indicating effective infection management.
Area of Science:
- Pharmacology
- Nephrology
- Infectious Diseases
Background:
- Chronic renal failure (CRF) presents challenges for antibiotic selection.
- Urinary and respiratory tract infections are common complications in CRF patients.
- Co-trimoxazole is a frequently used antibiotic, but its use in renal impairment requires careful consideration.
Purpose of the Study:
- To evaluate the safety and efficacy of co-trimoxazole in patients with chronic renal failure.
- To assess the impact of co-trimoxazole treatment on renal function in CRF patients.
- To determine appropriate dosing guidelines for co-trimoxazole in this population.
Main Methods:
- Prospective study involving twenty patients with CRF and documented infections.
- Treatment administered with co-trimoxazole.
- Renal function monitored throughout the treatment period.
- Dose adjustments based on the degree of renal failure.
Main Results:
- Seventeen out of twenty patients (85%) showed no deterioration in renal function.
- Renal function decline in the remaining three patients was attributed to causes unrelated to co-trimoxazole.
- Co-trimoxazole effectively treated urinary and respiratory tract infections in the study cohort.
Conclusions:
- Co-trimoxazole can be safely administered to patients with chronic renal failure.
- Dose adjustment according to the level of renal impairment is crucial for safe use.
- Co-trimoxazole represents a viable treatment option for infections in CRF patients with appropriate dosing.